Roche Analyst Event at ASCO 2016

Roche Analyst Event at ASCO: Sunday, 5 June 2016, 6:30pm CDT


  • Oncology strategy and outlook
    Daniel O’Day, CEO Roche Pharmaceuticals
  • Early pipeline update: assets and strategies
    Ira Mellman, gRED: Ph.D., Vice President, Cancer Immunology, Genentech
    William Pao, pRED: M.D., Ph.D., Global Head Oncology Discovery and Translational Area, Roche
  • Roche highlights in cancer immunotherapy
    Daniel S. Chen, M.D. , Ph.D., VP, Global Head of Cancer Immunotherapy Global Product Development, Genentech/Roche
  • Targeted therapies and future combinations
    Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development

Audio Webcast